 Connection
Qiang Fu to Immunotherapy
This is a "connection" page, showing publications Qiang Fu has written about Immunotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.487 |
|
|
|
-
Wang Y, Li H, Lin J, Li Y, Zhang K, Li H, Fu Q, Jiang Y. Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma. Nat Commun. 2025 Feb 22; 16(1):1876.
Score: 0.202
-
Fu Q, Zhao X, Hu J, Jiao Y, Yan Y, Pan X, Wang X, Jiao F. mRNA vaccines in the context of cancer treatment: from concept to application. J Transl Med. 2025 Jan 06; 23(1):12.
Score: 0.200
-
Guo R, Li J, Hu J, Fu Q, Yan Y, Xu S, Wang X, Jiao F. Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy. Int Immunopharmacol. 2023 Jul; 120:110417.
Score: 0.045
-
Wang Z, Liu Y, Peng L, Till B, Liao Y, Yuan S, Yan X, Chen L, Fu Q, Qin Z. Role of fibrosarcoma-induced CD11b+ myeloid cells and tumor necrosis factor-a in B cell responses. Oncogene. 2022 03; 41(10):1434-1444.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|